Non-alcoholic Fatty Liver Disease
"Non-alcoholic Fatty Liver Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Fatty liver finding without excessive ALCOHOL CONSUMPTION.
| Descriptor ID |
D065626
|
| MeSH Number(s) |
C06.552.241.519
|
| Concept/Terms |
Non-alcoholic Fatty Liver Disease- Non-alcoholic Fatty Liver Disease
- Non alcoholic Fatty Liver Disease
- NAFLD
- Nonalcoholic Fatty Liver Disease
- Fatty Liver, Nonalcoholic
- Fatty Livers, Nonalcoholic
- Liver, Nonalcoholic Fatty
- Livers, Nonalcoholic Fatty
- Nonalcoholic Fatty Liver
- Nonalcoholic Fatty Livers
Nonalcoholic Steatohepatitis- Nonalcoholic Steatohepatitis
- Nonalcoholic Steatohepatitides
- Steatohepatitides, Nonalcoholic
- Steatohepatitis, Nonalcoholic
|
Below are MeSH descriptors whose meaning is more general than "Non-alcoholic Fatty Liver Disease".
Below are MeSH descriptors whose meaning is more specific than "Non-alcoholic Fatty Liver Disease".
This graph shows the total number of publications written about "Non-alcoholic Fatty Liver Disease" by people in this website by year, and whether "Non-alcoholic Fatty Liver Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 1 | 2 |
| 2016 | 4 | 1 | 5 |
| 2017 | 2 | 1 | 3 |
| 2018 | 5 | 1 | 6 |
| 2019 | 2 | 0 | 2 |
| 2020 | 3 | 0 | 3 |
| 2021 | 3 | 0 | 3 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Non-alcoholic Fatty Liver Disease" by people in Profiles.
-
Maternal Pyrroloquinoline Quinone Supplementation Improves Offspring Liver Bioactive Lipid Profiles throughout the Lifespan and Protects against the Development of Adult NAFLD. Int J Mol Sci. 2022 May 27; 23(11).
-
Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis. Cell Mol Gastroenterol Hepatol. 2021; 12(3):1001-1019.
-
Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin-Like Phospholipase Domain Containing 3-Mediated Acceleration of Steatohepatitis. Hepatology. 2021 04; 73(4):1290-1306.
-
Role of necroptosis in chronic hepatic inflammation and fibrosis in a mouse model of increased oxidative stress. Free Radic Biol Med. 2021 02 20; 164:315-328.
-
Pediatric Non-Alcoholic Fatty Liver Disease: Nutritional Origins and Potential Molecular Mechanisms. Nutrients. 2020 Oct 16; 12(10).
-
Steatohepatitic Variant of Hepatocellular Carcinoma Is Associated With Both Alcoholic Steatohepatitis and Nonalcoholic Steatohepatitis: A Study of 2 Cohorts With Molecular Insights. Am J Surg Pathol. 2020 10; 44(10):1406-1412.
-
The effect of sleep on gastrointestinal functioning in common digestive diseases. Lancet Gastroenterol Hepatol. 2020 06; 5(6):616-624.
-
Prevalence of NAFLD in Guatemala following exposure to a protein-energy nutrition intervention in early life. Ann Hepatol. 2020 Jul - Aug; 19(4):373-379.
-
Gene Expression Predicts Histological Severity and Reveals Distinct Molecular Profiles of Nonalcoholic Fatty Liver Disease. Sci Rep. 2019 08 29; 9(1):12541.
-
Current Models of Fatty Liver Disease; New Insights, Therapeutic Targets and Interventions. Adv Exp Med Biol. 2019; 1134:33-58.